Rural hypertension gap: AHA calls for telehealth, team-based care, better medication access

Clinical Takeaway: Screen for access barriers (transportation, pharmacy deserts, cost) at every visit and prioritize home BP monitoring, telehealth, and pharmacist-supported care to improve control in rural patients.

Hypertension affects nearly half of US adults, yet control rates remain strikingly low—and even worse in rural communities, where prevalence is higher and control rates lag behind urban areas. This new American Heart Association (AHA) scientific statement emphasizes that closing the rural hypertension gap requires tackling structural barriers alongside optimizing evidence-based therapy.

Rural patients face a convergence of challenges: fewer clinicians, longer travel distances, lower health literacy, and reduced access to pharmacies. These factors delay diagnosis, limit medication access, and hinder treatment intensification—even though antihypertensive therapies are widely available and effective.

“Expanding services such as telehealth, deploying mobile health units, and implementing team-based management approaches…can improve hypertension management,” the authors note, underscoring that solutions must be tailored to local context and culture.

Key recommendations and insights

The statement reinforces guideline-directed BP targets (<130/80 mm Hg for most patients) but stresses that achieving them in rural populations requires adaptation in care delivery:

• Leverage home BP monitoring and telehealth: Home BP monitoring (Class I recommendation in prior guidelines) combined with remote feedback, telecounseling, or algorithm-driven titration improves control and is especially valuable where access to in-person care is limited.
• Expand team-based care models: Pharmacists, nurses, dietitians, and community health workers can reduce therapeutic inertia, optimize medication regimens, and address adherence and cost barriers.
• Address medication access—not just adherence: Rural–urban differences in BP control are not explained by adherence alone; pharmacy deserts, insurance gaps, and cost barriers often limit whether patients can obtain medications in the first place.
• Use cost-conscious prescribing strategies: Although many antihypertensives are generic, affordability remains variable. Fixed-dose combinations may improve adherence, while clinicians should routinely assess copays and coverage and consider lower-cost alternatives.
• Engage pharmacists to improve outcomes: Pharmacist-led or collaborative care models can improve BP control and help navigate formulary and cost issues—especially critical in areas with physician shortages.
• Deploy mobile clinics and community-based interventions: Bringing care closer to patients can offset transportation barriers and improve monitoring, education, and treatment intensification.
• Tailor lifestyle interventions to local context: Dietary changes (e.g., DASH) and healthy food access strategies must reflect rural realities, including food deserts and higher rates of food insecurity.

The statement also highlights emerging tools—such as remote monitoring platforms, SMS-based care, and AI-supported decision-making—as promising but dependent on improving broadband and digital literacy in rural areas.

Medication-focused considerations

Drug therapy remains central, but the statement reframes barriers:

• Rural patients have similar adherence rates as urban populations, suggesting access and affordability—not behavior—drive disparities.
• Up to 56.8% of rural residents live in pharmacy deserts, limiting timely access to antihypertensives.
• Patients may engage in cost-saving behaviors (dose skipping, splitting pills), underscoring the need for proactive cost discussions and regimen simplification.

Bottom line

Improving hypertension outcomes in rural populations requires more than intensifying medications—it demands redesigning care delivery. Clinicians should integrate home BP monitoring, partner with pharmacists and community health workers, and proactively identify barriers to medication access and affordability to meaningfully improve BP control.

Source: Ford CD, et al. 2026 June 25. Circulation. Rural Health and Health Disparities in Hypertension Management: A Scientific Statement From the American Heart Association